The Company Profile of Chengdu Kaijie Trade Co., Ltd
 
  Sign In Join Help
 
Chengdu Kaijie Trade Co., Ltd

 
  Recommended Results
  Company Description
About Us
Chengdu Kaijie Biopharm Co. Ltd. (KJBP) is one of the leading peptide manufacturers in China. It was founded in Chengdu in March, 2003 by a team of experienced peptide chemists with a combined industrial experience over 20 years.


KJBP has oriented its business along two main lines:the investigation,development,production and commercialization of generic bulk peptide APIs for the international markets,and custom synthesis service for buliding blocks,amino acid resin and peptide sequences which meet researchers’ specific demand worldwide.


Dayi campus in the suburb of Chengdu city provides KJBP with a good infrastructure for both industrial-scale production of peptides and Custom Synthesis.The pharmaceutical grade solid phase peptide synthesis in Dayi campus can meet USP, EP or the requirements of CP, single batches are up to Kg scales.


KJBP has begun to implement the 2008 development plan which is improving quality management standards and increasing production scale.Currently Chinese GMP is accomplished and the US FDA preparatory work is also under way as scheduled.

Our Mission
To combine innovation with excellence by developing and manufacturing quality peptide accompanied by professional and friendly scientific support.
Chengdu Kaijie Biopharm Co. Milestone:

2001 Chengdu Shengnuo Group, which was the core company of Chengdu Kaijie Biopharm Co., was established in 2001. It was composed of the main group of managers from various departments of the top pharmaceutical companies. Becauseof inherent success of peptide synthesis technology, we well prepared for laborary construction in future research and development.

2002 Chengdu Shengnuo Group renovated a small laboratory for the production process. The company purchased R & D Division''s first batch of equipment. Chendu Shengnuo'' R & D personnel and the University of Southern California Department of Chemistry held technical exchanges to develop international standards of peptide synthesis methods and research.

2003 Chengdu Kaijie Biopharm Co., Ltd. established its business as peptide product development and customized synthesis service. Added 3 laboratory facilities, laboratory personnel had increased to 12. Improved equipment, imported CSBio automatic peptide synthesis apparatus and multi-flux synthetic instrument, to keep pace with expansion of large custom synthesis business.

2004 The company focused on the development of peptide APIs, Thymosin, and Somatostatin Thymopentin products.

2005 Investment of seventy million yuan was made in Dayi Industrial Park which covers an area of more than ten hectares.
At the same time all aspects of integration and marketing, industry conference and exhibition of International Peptide API were being developed.

2006 Dayi Industrial Park was completed. The new factory was distinguished by three areas of production, peptide synthesis pilot facility, custom peptide synthesis R & D Center, and Generic API workshop.

2007 Company started preparing for examination and approval of related drugs through worlding with University of Cambridge chemists. Facilities in Sichuan Province became one of the fastest growing companies in China.

2008 Chengdu Kaijie Biopharm Co. along with twelve local pharmaceutical companies entered into with the U.S. long-term Raw materials contract, made supply agreements with Europe, India and other places around the world. In the same year, company received thymopentin API GMP certification.

2009 Chengdu Sino-bio Trade Import and Export Trade Co., Ltd, subsidiary of Shengnuo Group, set out to establish international business development relations. Company made preparations for GMP certification, went into production of more 20 new products, and was India''s largest manufacturers of pharmaceutical raw materials imports.

2010 The company started construction of new production plant, expected to be built in 2011 and received U.S. FDA Certification.

Kaijie Culture
KJBP(ShengNuo Group) is one of the leading peptide manufactures in China.
We are dedicated to providing clients with the highest quality of peptide products and the best customer service in the world.

Awards and Certificate
Chengdu Kaijie Biopharm Co. is a leading supplier of peptidic active pharmaceutical ingredients (APIs) and comprehensive custom peptide synthesis services. Its Group Company, Chengdu Shengnuo Group, was founded in 2001 by five private companies which focuses on research grade peptides, cGMP grade peptides and related trading businesses.
  ProductsKeyword
Peptide APIs, Peptide for Injection, Cosmetic peptides, custom synthesis, Ipamorelin, Abarelix, Alarelin, Angiotensin, Antide, Argipressin, Atosiban, HGH176-191, CJC-1295, MGF, Sermorelin, Leuprorelin, Ziconotide, Hexarelin, Melanotan

  Contact information
Company :  Chengdu Kaijie Trade Co., Ltd
Email:  Contact us
URL:  ********
Phone:  *********
Fax :  *********
Country :  China
Address :  *********

  Showroom
1. Argirelin Acetate (Acetyl Hexapeptide-3)
Commerce Member:
Please log in your ID and password, we will later fill in relating info.
 
ID: Password: Remember my ID on this computer
Complete this form below to send out your enquiries.
All enquiries will be automatically sent to the company you want to develop.
Subject
Content (Don't input Company Name, E-Mail, Phone Number, Fax Number, and URL)
   

 


Company Profile:
* Company Name
*E-mail
*Country
*Contact Person
URL
*Phone
- -
Fax
- -
*Postal code
*City
*Street Address
*Business Nature
Distributor   Exporter Importer Manufacturer
Whole Sale Retailer  Reseller Retrofitter User
Others, please specify:
*Security Code
Enter the security code.


Site Map l   Privacy Policy l Company Profile l Corporate Proposal l Contact Us l Help l Advertise With Us l  World Trade Link
Copyright©2022, G.T. Internet Information Co., Ltd. All Rights Reserved.     .